These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9473684)
1. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Ranganathan S; Dexter DW; Benetatos CA; Hudes GR Biochim Biophys Acta; 1998 Jan; 1395(2):237-45. PubMed ID: 9473684 [TBL] [Abstract][Full Text] [Related]
2. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells. Ranganathan S; McCauley RA; Dexter DW; Hudes GR Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260 [TBL] [Abstract][Full Text] [Related]
3. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance. Ranganathan S; Dexter DW; Benetatos CA; Chapman AE; Tew KD; Hudes GR Cancer Res; 1996 Jun; 56(11):2584-9. PubMed ID: 8653701 [TBL] [Abstract][Full Text] [Related]
5. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression. Sangrajrang S; Denoulet P; Laing NM; Tatoud R; Millot G; Calvo F; Tew KD; Fellous A Biochem Pharmacol; 1998 Feb; 55(3):325-31. PubMed ID: 9484799 [TBL] [Abstract][Full Text] [Related]
6. Effects of microtubule inhibitors-taxol, vinblastine and estramustine on the growth and p53 gene expression in the hormone independent human prostatic JCA-1 cells. Darby E; An S; Ng C; Hsieh TC; Mallouh C; Wu JM Anticancer Res; 1996; 16(6B):3647-52. PubMed ID: 9042236 [TBL] [Abstract][Full Text] [Related]
7. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells. Kanakkanthara A; Northcote PT; Miller JH Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309 [TBL] [Abstract][Full Text] [Related]
9. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer. Wang W; Zhang H; Wang X; Patterson J; Winter P; Graham K; Ghosh S; Lee JC; Katsetos CD; Mackey JR; Tuszynski JA; Wong GK; Ludueña RF Protoplasma; 2017 May; 254(3):1163-1173. PubMed ID: 27943021 [TBL] [Abstract][Full Text] [Related]
10. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. Kamath K; Wilson L; Cabral F; Jordan MA J Biol Chem; 2005 Apr; 280(13):12902-7. PubMed ID: 15695826 [TBL] [Abstract][Full Text] [Related]
11. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. Speicher LA; Barone L; Tew KD Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706 [TBL] [Abstract][Full Text] [Related]
12. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status. Serafin AM; Akudugu JM; Bohm L Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116 [TBL] [Abstract][Full Text] [Related]
13. Identification of betaIII- and betaIV-tubulin isotypes in cold-adapted microtubules from Atlantic cod (Gadus morhua): antibody mapping and cDNA sequencing. Modig C; Olsson PE; Barasoain I; de Ines C; Andreu JM; Roach MC; Ludueña RF; Wallin M Cell Motil Cytoskeleton; 1999; 42(4):315-30. PubMed ID: 10223637 [TBL] [Abstract][Full Text] [Related]
14. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression. Wehbe H; Kearney CM; Pinney KG Anticancer Res; 2005; 25(6B):3865-70. PubMed ID: 16309172 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype. Lopus M; Smiyun G; Miller H; Oroudjev E; Wilson L; Jordan MA Cancer Chemother Pharmacol; 2015 Nov; 76(5):1013-24. PubMed ID: 26416565 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action. Panda D; Miller HP; Islam K; Wilson L Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674 [TBL] [Abstract][Full Text] [Related]
17. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Alli E; Bash-Babula J; Yang JM; Hait WN Cancer Res; 2002 Dec; 62(23):6864-9. PubMed ID: 12460900 [TBL] [Abstract][Full Text] [Related]
18. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine. Hari M; Wang Y; Veeraraghavan S; Cabral F Mol Cancer Ther; 2003 Jul; 2(7):597-605. PubMed ID: 12883031 [TBL] [Abstract][Full Text] [Related]
19. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Dumontet C; Duran GE; Steger KA; Beketic-Oreskovic L; Sikic BI Cancer Res; 1996 Mar; 56(5):1091-7. PubMed ID: 8640766 [TBL] [Abstract][Full Text] [Related]
20. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Gan PP; Pasquier E; Kavallaris M Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]